New Long-Term Study Results Presented at 16th International Congress of Parkinson's Disease and Movement Disorders
DUBLIN,
June 18, 2012 Today Abbott (NYSE: ABT) announced results from five
abstracts evaluating levodopa-carbidopa intestinal gel (LCIG), its
investigational compound for advanced Parkinson's disease Read more
إرسال تعليق